Search results
Taysha Gene Therapies (NASDAQ:TSHA) Receives “Buy” Rating from Needham & Company LLC
ETF DAILY NEWS· 3 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports ...